Loading
Loading
Your feedback directly shapes Sporos.
Sign in to track your feedback history
Reducing Hereditary Cancer Act of 2025 This bill provides for Medicare coverage of germline mutation testing for individuals with a personal or family history of a hereditary cancer gene mutation or suspected history of hereditary cancer, as well as for associated coverage of risk-reducing surgeries and screenings.
Introduced
Sep 10, 2025
Last Action
Sep 10, 2025
Session
119th Congress
Sponsors
1 primary · 1 co
Passage Probability
2% — Very Low
Introduced in Senate
Read twice and referred to the Committee on Finance.
Get a plain-English explanation of what this bill does, who it affects, and why it matters.
2%
Estimate based on legislative signals
See what factors are driving this score — cosponsor support, bipartisan backing, committee progress, and more.
Upgrade to ProRead twice and referred to the Committee on Finance.